University of California, Irvine: Lung Neoplasms trials
The registry lists 10 Lung Neoplasms studies with University of California, Irvine as lead sponsor. 5 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 1 1Phase 2 2No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)RecruitingNCT07711691Not applicable
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialRecruitingNCT07447050Phase 2
- Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung CancerRecruitingNCT07062172Not applicable
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Analysis of Lung Cancer Tissue With Spatial Frequency Domain ImagingEnrolling by invitationNCT06549088
- Empowering Patients' Lung Cancer Screening UptakeCompletedNCT06000683Not applicableResults posted
- Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)CompletedNCT06225414Not applicable
- A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-ArmCompletedNCT05555342Early Phase 1
- Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsActive, not recruitingNCT05334329Phase 1
- Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate CancerWithdrawnNCT00581503